(Updates with Boston Scientific trial excerpt in third paragraph.) May 11 (Bloomberg) -- Boston Scientific Corp., which makes coronary stents to repair clogged arteries, won more than $19 million in patent-infringement damages from...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Scientific Wins $19 Million Stent Damages From Cordis
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account